FDA Inspection
AstraZeneca Pharmaceuticals, LPAstraZeneca Pharmaceuticals, LP – FDA Inspection, Aug 27, 2014
Record Details
This FDA Inspection record concerns AstraZeneca Pharmaceuticals, LP, with an inspection on August 27, 2014, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- August 27, 2014
- Product Type
- Drugs
View Company Profile
ID · 85d228df-13a6-44d7-8489-95ab6bab3f22
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 895233
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
1- 21 CFR 211.67(b)Written procedures fail to include
Full citation text and observation details available on the Dashboard.
Other FDA inspections of AstraZeneca Pharmaceuticals, LP
7| Date | Classification | Office | Project area |
|---|---|---|---|
| June 26, 2026 | Not classified | Philadelphia District Office | Drug Quality Assurance |
| April 26, 2024 | Not classified | Philadelphia District Office | |
| July 19, 2023 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 24, 2017 | NAI | Center for Food Safety and Applied Nutrition | Foodborne Biological Hazards |
| November 28, 2011 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for AstraZeneca Pharmaceuticals, LP
- FDA Inspection 1327360 - 2026-06-26
- FDA Inspection 1236034 - 2024-04-26
- FDA Inspection 1211584 - 2023-07-19
- FDA Inspection 1022686 - 2017-08-24
- FDA Inspection 788561 - 2011-11-28
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.